Clinical Trials Directory

Trials / Unknown

UnknownNCT00155376

Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (planned)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.

Detailed description

Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.

Conditions

Interventions

TypeNameDescription
DRUGmorphine and glucagon

Timeline

Start date
2005-09-01
Completion
2005-09-01
First posted
2005-09-12
Last updated
2005-11-28

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00155376. Inclusion in this directory is not an endorsement.